Shuang Ma

机构：Mongolian University of Science and Technology, University of International Business and Economics, Dalian Medical University, Sheng Jing Hospital, Zhejiang Lab, First Hospital of China Medical University, First Affiliated Hospital of Dalian Medical University, Inner Mongolia University of Technology, Qiqihar Medical University, China Medical University · ORCID：0000-0001-8776-7375

发表论文 93 篇 · 总被引 1209 次 · h-index 20

代表论文

• A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease (2022 · npj Parkinson s Disease · 被引 39)
• Pinocembrin Inhibits the Proliferation and Metastasis of Breast Cancer via Suppression of the PI3K/AKT Signaling Pathway (2021 · Frontiers in Oncology · 被引 38)
• Inhibition of PI3K and MAPK pathways along with KIT inhibitors as a strategy to overcome drug resistance in gastrointestinal stromal tumors (2021 · PLoS ONE · 被引 20)
• A Quad-Functional On-demand released nanomissile achieves cascade amplification therapy of Triple-Negative breast cancer through reversing multiple resistance (2023 · Chemical Engineering Journal · 被引 14)
• Epithelioid hemangioendothelioma ( EHE ) with WWTR1::TFE3 gene fusion, a novel fusion variant (2024 · Genes Chromosomes and Cancer · 被引 13)
• A multifunctional ‘golden cicada’ nanoplatform breaks the thermoresistance barrier to launch cascade augmented synergistic effects of photothermal/gene therapy (2023 · Journal of Nanobiotechnology · 被引 9)